drugset / Trial / NCT01577589

A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects

NCT01577589

Phase 1 Completed 34 enrolled Pfizer
RandomizedCrossoverTriple-blindBasic science

Summary

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of Ceftaroline 600 mg when administered by varying infusion volumes.

Timeline

Start
2012-04
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline Other / unclassified 600 mg Intravenous

Indications

No indication recorded.